Trump To Sign Bill Which Could Potentially Federally Legalize Cannabis, Psilocybin, & MDMA For The Terminally Ill Thanks To MAPS

“President Trump is set to sign legislation which could make medical marijuana federally legal for terminally ill patients. The bill, known as the “Right to Try Act,” would allow patients with potentially fatal conditions to try medications that have not yet been approved by the FDA, but are undergoing the approval process and have already passed the first phase of clinical studies.

Right to Try was passed unanimously by the Senate last summer and by the House of Representatives on Tuesday in a vote of 250 to 169.

While the bill’s provisions are targeted at a wide range of medications, it appears they might also apply to medical cannabis thanks to a clinical trial being conducted by the Multidisciplinary Association of Psychedelic Sciences (MAPS).

The MAPS trial, currently in the second phase of the FDA approval process, is testing the effectiveness of smoked cannabis in veterans with PTSD and meets all of the criteria set out by the Right to Try.

The majority of states already have their own form of Right to Try legislation, with one notable exception being New York. In Utah, a recently passed law specifically addresses the right of terminally ill patients to try cannabis. However, because cannabis remains federally prohibited, even if a terminally ill patient has the “Right to Try” cannabis on the state level, they’re still in violation of federal law. The Right to Try bill, recently passed by Congress, would change that. In addition to cannabis, MDMA and psilocybin could also potentially be used by ‘eligible patients’ since FDA trials of both substances meet the requirements set out in the federal bill.”

We are primarily funded by readers. Please subscribe and donate to support us!

Read More:

herb.co/marijuana/news/trump-right-to-try-marijuana-cannabis

House Votes List:

clerk.house.gov/evs/2018/roll214.xml
(It appears all 169 Nays were Demoncrats)

h/t SN7

Views:

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.